BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29343809)

  • 21. Impact of metabolic syndrome on the survival of Chinese patients with resectable esophageal squamous cell carcinoma.
    Wen YS; Huang C; Zhang X; Qin R; Lin P; Rong T; Zhang LJ
    Dis Esophagus; 2016 Aug; 29(6):607-13. PubMed ID: 26123618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between metabolic syndrome and the incidence of colorectal cancer.
    Lee J; Lee KS; Kim H; Jeong H; Choi MJ; Yoo HW; Han TH; Lee H
    Environ Health Prev Med; 2020 Feb; 25(1):6. PubMed ID: 32075578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer.
    Xu G; Jiang L; Ye C; Qin G; Luo Z; Mo Y; Chen J
    Front Immunol; 2021; 12():724429. PubMed ID: 34512652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors.
    Gong J; Hutter C; Baron JA; Berndt S; Caan B; Campbell PT; Casey G; Chan AT; Cotterchio M; Fuchs CS; Gallinger S; Giovannucci E; Harrison T; Hayes R; Hsu L; Jiao S; Lin Y; Lindor NM; Newcomb P; Pflugeisen B; Phipps AI; Rohan T; Schoen R; Seminara D; Slattery ML; Stelling D; Thomas F; Warnick G; White E; Potter J; Peters U
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1974-85. PubMed ID: 23001243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-operative aspirin use and colorectal cancer-specific survival in patients with stage I-III colorectal cancer.
    Goh CH; Leong WQ; Chew MH; Pan YS; Tony LK; Chew L; Tan IB; Toh HC; Tang CL; Fu WP; Chia WK
    Anticancer Res; 2014 Dec; 34(12):7407-14. PubMed ID: 25503181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome is a predictor of all site and liver-specific recurrence following primary resection of colorectal cancer: Prospective cohort study of 1006 patients.
    Bhome R; Peppa N; Karar S; McDonnell D; Mirnezami A; Hamady Z
    Eur J Surg Oncol; 2021 Jul; 47(7):1623-1628. PubMed ID: 33483238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis.
    Wong CK; Law WL; Wan YF; Poon JT; Lam CL
    BMC Cancer; 2014 May; 14():337. PubMed ID: 24886385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of smoking and metabolic syndrome for incidence of cardiovascular disease--comparison of relative contribution in urban Japanese population: the Suita study.
    Higashiyama A; Okamura T; Ono Y; Watanabe M; Kokubo Y; Okayama A
    Circ J; 2009 Dec; 73(12):2258-63. PubMed ID: 19838005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Metabolic Syndrome on Colorectal Cancer Prognosis after Primary Surgery.
    Tao W; Yuan C; Kang B; Liu XY; Cheng YX; Zhang B; Wei ZQ; Peng D
    Nutr Cancer; 2023; 75(1):331-338. PubMed ID: 35976038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a prognostic value of tumor location among Chinese patients with colorectal cancer?
    Liu F; Li C; Jia H; Yang L; Wu Y; Zhao J; Cai S; Zhu J; Xu Y
    Oncotarget; 2017 Jun; 8(24):38682-38692. PubMed ID: 28418874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
    Sho S; Court CM; Winograd P; Russell MM; Tomlinson JS
    J Surg Oncol; 2017 Dec; 116(8):996-1004. PubMed ID: 28767131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking induces the occurrence of colorectal cancer via changing the intestinal permeability.
    Wang H; Chen X; Gao Q; Liu K; Bi G; Deng J; Zhang X
    J BUON; 2021; 26(3):1009-1015. PubMed ID: 34268966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A high preoperative carbohydrate antigen 19-9 level is a risk factor for recurrence in stage II colorectal cancer.
    Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Murono K; Watanabe T
    Acta Oncol; 2017 May; 56(5):634-638. PubMed ID: 27885879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of three endothelial nitric oxide synthase (eNOS) polymorphisms and metabolic syndrome (MetS) in patients with colorectal cancer.
    Ko EJ; Kim EJ; Cho HJ; Oh J; Park HS; Ryu CS; Kim JO; Jun HH; Chong SY; Kim JW; Kim NK
    Genes Genomics; 2022 Jun; 44(6):659-670. PubMed ID: 35377131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of smoking in addition to established risk factors in patients with Dukes B and C colorectal cancer: a retrospective analysis.
    Diamantis N; Xynos ID; Amptulah S; Karadima M; Skopelitis H; Tsavaris N
    J BUON; 2013; 18(1):105-15. PubMed ID: 23613395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and genomic characteristics of metabolic syndrome in colorectal cancer.
    Li Y; Zhao J; Wu X; Zhang Y; Jin Y; Cai W
    Aging (Albany NY); 2021 Feb; 13(4):5442-5460. PubMed ID: 33582655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer.
    Liu T; Fan Y; Zhang Q; Wang Y; Yao N; Song M; Zhang Q; Cao L; Song C; Shi H
    Inflamm Res; 2022 Aug; 71(7-8):899-909. PubMed ID: 35715516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of metabolic syndrome on survival of patients with localized renal clear cell carcinoma: A retrospective cohort study in China.
    Liang Y; Zhang C; Luo J; He Y; Zhang Y; Quan Z; Yang L
    Urol Oncol; 2023 May; 41(5):257.e19-257.e26. PubMed ID: 36967252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive interaction of snoring and body mass index on the prevalence of metabolic syndrome among Chinese coal mine employees: a cross-sectional study.
    Li Y; Gao Q; Li L; Shen Y; Lu Q; Huang J; Sun C; Wang H; Qiao N; Wang C; Zhang H; Wang T
    BMC Endocr Disord; 2019 Mar; 19(1):28. PubMed ID: 30832625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients.
    Zarzavadjian Le Bian A; Denet C; Tabchouri N; Donatelli G; Wind P; Louvet C; Bennamoun M; Christidis C; Perniceni T; Fuks D; Gayet B
    Langenbecks Arch Surg; 2018 Jun; 403(4):443-450. PubMed ID: 29704123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.